Click for best price
Anthrax Treatment Market Size, Share 2024
| Market size in 2023 |
US$ 574.9 million
|
Forecast Market size by 2030 |
US$ 928.1 million
|
| Growth Rate |
CAGR of 7.1% |
Number of Pages |
128 Pages |
The global Anthrax Treatment market was valued at US$ 574.9 million in 2023 and is projected to reach US$ 928.1 million by 2030, at a CAGR of 7.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Fluoroquinolone Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anthrax Treatment include Alembic Pharmaceuticals, Integrated Bio Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Zydus Group, Bayer AG, Pfizer Inc., EMERGENT, Sanofi and Elusys Therapeutics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Anthrax is a serious infectious disease caused by gram-positive, rod-shaped bacteria known as Bacillus anthracis. It occurs naturally in soil and commonly affects domestic and wild animals around the world. People can get sick with anthrax if they come in contact with infected animals or contaminated animal products.
This report aims to provide a comprehensive presentation of the global market for Anthrax Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthrax Treatment. This report contains market size and forecasts of Anthrax Treatment in global, including the following market information:
- Global Anthrax Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Anthrax Treatment Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Anthrax Treatment companies in 2023 (%)
We surveyed the Anthrax Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthrax Treatment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anthrax Treatment Market Segment Percentages, by Type, 2023 (%)
- Fluoroquinolone
- Tetracycline
- Others
Global Anthrax Treatment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anthrax Treatment Market Segment Percentages, by Application, 2023 (%)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anthrax Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anthrax Treatment Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anthrax Treatment revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Anthrax Treatment revenues share in global market, 2023 (%)
- Key companies Anthrax Treatment sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Anthrax Treatment sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Alembic Pharmaceuticals
- Integrated Bio Therapeutics Inc.
- Sun Pharmaceutical Industries Ltd.
- Zydus Group
- Bayer AG
- Pfizer Inc.
- EMERGENT
- Sanofi
- Elusys Therapeutics
- Porton Biopharma
- Lupin
- Soligenix
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- ARISTO Pharmaceuticals Private Limited
- INDOCO REMEDIES LTD.
- Paratek Pharmaceuticals, Inc.
- DEINOVE
- BlueWillow Biologics.
- GC Biopharma, corp.
- Altimmune
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anthrax Treatment, market overview.
Chapter 2: Global Anthrax Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Anthrax Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anthrax Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anthrax Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anthrax Treatment Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 574.9 million
|
| Forecast Market size by 2030 |
US$ 928.1 million
|
| Growth Rate |
CAGR of 7.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
128 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anthrax Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anthrax Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anthrax Treatment Overall Market Size
2.1 Global Anthrax Treatment Market Size: 2023 VS 2030
2.2 Global Anthrax Treatment Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Anthrax Treatment Sales: 2019-2030
3 Company Landscape
3.1 Top Anthrax Treatment Players in Global Market
3.2 Top Global Anthrax Treatment Companies Ranked by Revenue
3.3 Global Anthrax Treatment Revenue by Companies
3.4 Global Anthrax Treatment Sales by Companies
3.5 Global Anthrax Treatment Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Anthrax Treatment Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Anthrax Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anthrax Treatment Players in Global Market
3.8.1 List of Global Tier 1 Anthrax Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Anthrax Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anthrax Treatment Market Size Markets, 2023 & 2030
4.1.2 Fluoroquinolone
4.1.3 Tetracycline
4.1.4 Others
4.2 By Type - Global Anthrax Treatment Revenue & Forecasts
4.2.1 By Type - Global Anthrax Treatment Revenue, 2019-2024
4.2.2 By Type - Global Anthrax Treatment Revenue, 2025-2030
4.2.3 By Type - Global Anthrax Treatment Revenue Market Share, 2019-2030
4.3 By Type - Global Anthrax Treatment Sales & Forecasts
4.3.1 By Type - Global Anthrax Treatment Sales, 2019-2024
4.3.2 By Type - Global Anthrax Treatment Sales, 2025-2030
4.3.3 By Type - Global Anthrax Treatment Sales Market Share, 2019-2030
4.4 By Type - Global Anthrax Treatment Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anthrax Treatment Market Size, 2023 & 2030
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Anthrax Treatment Revenue & Forecasts
5.2.1 By Application - Global Anthrax Treatment Revenue, 2019-2024
5.2.2 By Application - Global Anthrax Treatment Revenue, 2025-2030
5.2.3 By Application - Global Anthrax Treatment Revenue Market Share, 2019-2030
5.3 By Application - Global Anthrax Treatment Sales & Forecasts
5.3.1 By Application - Global Anthrax Treatment Sales, 2019-2024
5.3.2 By Application - Global Anthrax Treatment Sales, 2025-2030
5.3.3 By Application - Global Anthrax Treatment Sales Market Share, 2019-2030
5.4 By Application - Global Anthrax Treatment Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Anthrax Treatment Market Size, 2023 & 2030
6.2 By Region - Global Anthrax Treatment Revenue & Forecasts
6.2.1 By Region - Global Anthrax Treatment Revenue, 2019-2024
6.2.2 By Region - Global Anthrax Treatment Revenue, 2025-2030
6.2.3 By Region - Global Anthrax Treatment Revenue Market Share, 2019-2030
6.3 By Region - Global Anthrax Treatment Sales & Forecasts
6.3.1 By Region - Global Anthrax Treatment Sales, 2019-2024
6.3.2 By Region - Global Anthrax Treatment Sales, 2025-2030
6.3.3 By Region - Global Anthrax Treatment Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Anthrax Treatment Revenue, 2019-2030
6.4.2 By Country - North America Anthrax Treatment Sales, 2019-2030
6.4.3 US Anthrax Treatment Market Size, 2019-2030
6.4.4 Canada Anthrax Treatment Market Size, 2019-2030
6.4.5 Mexico Anthrax Treatment Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Anthrax Treatment Revenue, 2019-2030
6.5.2 By Country - Europe Anthrax Treatment Sales, 2019-2030
6.5.3 Germany Anthrax Treatment Market Size, 2019-2030
6.5.4 France Anthrax Treatment Market Size, 2019-2030
6.5.5 U.K. Anthrax Treatment Market Size, 2019-2030
6.5.6 Italy Anthrax Treatment Market Size, 2019-2030
6.5.7 Russia Anthrax Treatment Market Size, 2019-2030
6.5.8 Nordic Countries Anthrax Treatment Market Size, 2019-2030
6.5.9 Benelux Anthrax Treatment Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Anthrax Treatment Revenue, 2019-2030
6.6.2 By Region - Asia Anthrax Treatment Sales, 2019-2030
6.6.3 China Anthrax Treatment Market Size, 2019-2030
6.6.4 Japan Anthrax Treatment Market Size, 2019-2030
6.6.5 South Korea Anthrax Treatment Market Size, 2019-2030
6.6.6 Southeast Asia Anthrax Treatment Market Size, 2019-2030
6.6.7 India Anthrax Treatment Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Anthrax Treatment Revenue, 2019-2030
6.7.2 By Country - South America Anthrax Treatment Sales, 2019-2030
6.7.3 Brazil Anthrax Treatment Market Size, 2019-2030
6.7.4 Argentina Anthrax Treatment Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anthrax Treatment Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Anthrax Treatment Sales, 2019-2030
6.8.3 Turkey Anthrax Treatment Market Size, 2019-2030
6.8.4 Israel Anthrax Treatment Market Size, 2019-2030
6.8.5 Saudi Arabia Anthrax Treatment Market Size, 2019-2030
6.8.6 UAE Anthrax Treatment Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Alembic Pharmaceuticals
7.1.1 Alembic Pharmaceuticals Company Summary
7.1.2 Alembic Pharmaceuticals Business Overview
7.1.3 Alembic Pharmaceuticals Anthrax Treatment Major Product Offerings
7.1.4 Alembic Pharmaceuticals Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.1.5 Alembic Pharmaceuticals Key News & Latest Developments
7.2 Integrated Bio Therapeutics Inc.
7.2.1 Integrated Bio Therapeutics Inc. Company Summary
7.2.2 Integrated Bio Therapeutics Inc. Business Overview
7.2.3 Integrated Bio Therapeutics Inc. Anthrax Treatment Major Product Offerings
7.2.4 Integrated Bio Therapeutics Inc. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.2.5 Integrated Bio Therapeutics Inc. Key News & Latest Developments
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.3.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.3.3 Sun Pharmaceutical Industries Ltd. Anthrax Treatment Major Product Offerings
7.3.4 Sun Pharmaceutical Industries Ltd. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.3.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.4 Zydus Group
7.4.1 Zydus Group Company Summary
7.4.2 Zydus Group Business Overview
7.4.3 Zydus Group Anthrax Treatment Major Product Offerings
7.4.4 Zydus Group Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.4.5 Zydus Group Key News & Latest Developments
7.5 Bayer AG
7.5.1 Bayer AG Company Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Anthrax Treatment Major Product Offerings
7.5.4 Bayer AG Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.5.5 Bayer AG Key News & Latest Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Anthrax Treatment Major Product Offerings
7.6.4 Pfizer Inc. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.6.5 Pfizer Inc. Key News & Latest Developments
7.7 EMERGENT
7.7.1 EMERGENT Company Summary
7.7.2 EMERGENT Business Overview
7.7.3 EMERGENT Anthrax Treatment Major Product Offerings
7.7.4 EMERGENT Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.7.5 EMERGENT Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Anthrax Treatment Major Product Offerings
7.8.4 Sanofi Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.8.5 Sanofi Key News & Latest Developments
7.9 Elusys Therapeutics
7.9.1 Elusys Therapeutics Company Summary
7.9.2 Elusys Therapeutics Business Overview
7.9.3 Elusys Therapeutics Anthrax Treatment Major Product Offerings
7.9.4 Elusys Therapeutics Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.9.5 Elusys Therapeutics Key News & Latest Developments
7.10 Porton Biopharma
7.10.1 Porton Biopharma Company Summary
7.10.2 Porton Biopharma Business Overview
7.10.3 Porton Biopharma Anthrax Treatment Major Product Offerings
7.10.4 Porton Biopharma Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.10.5 Porton Biopharma Key News & Latest Developments
7.11 Lupin
7.11.1 Lupin Company Summary
7.11.2 Lupin Anthrax Treatment Business Overview
7.11.3 Lupin Anthrax Treatment Major Product Offerings
7.11.4 Lupin Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.11.5 Lupin Key News & Latest Developments
7.12 Soligenix
7.12.1 Soligenix Company Summary
7.12.2 Soligenix Anthrax Treatment Business Overview
7.12.3 Soligenix Anthrax Treatment Major Product Offerings
7.12.4 Soligenix Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.12.5 Soligenix Key News & Latest Developments
7.13 Takeda Pharmaceutical Company Limited
7.13.1 Takeda Pharmaceutical Company Limited Company Summary
7.13.2 Takeda Pharmaceutical Company Limited Anthrax Treatment Business Overview
7.13.3 Takeda Pharmaceutical Company Limited Anthrax Treatment Major Product Offerings
7.13.4 Takeda Pharmaceutical Company Limited Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.13.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.14 Teva Pharmaceutical Industries Ltd.
7.14.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.14.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.14.3 Teva Pharmaceutical Industries Ltd. Anthrax Treatment Major Product Offerings
7.14.4 Teva Pharmaceutical Industries Ltd. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.14.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.15 ARISTO Pharmaceuticals Private Limited
7.15.1 ARISTO Pharmaceuticals Private Limited Company Summary
7.15.2 ARISTO Pharmaceuticals Private Limited Business Overview
7.15.3 ARISTO Pharmaceuticals Private Limited Anthrax Treatment Major Product Offerings
7.15.4 ARISTO Pharmaceuticals Private Limited Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.15.5 ARISTO Pharmaceuticals Private Limited Key News & Latest Developments
7.16 INDOCO REMEDIES LTD.
7.16.1 INDOCO REMEDIES LTD. Company Summary
7.16.2 INDOCO REMEDIES LTD. Business Overview
7.16.3 INDOCO REMEDIES LTD. Anthrax Treatment Major Product Offerings
7.16.4 INDOCO REMEDIES LTD. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.16.5 INDOCO REMEDIES LTD. Key News & Latest Developments
7.17 Paratek Pharmaceuticals, Inc.
7.17.1 Paratek Pharmaceuticals, Inc. Company Summary
7.17.2 Paratek Pharmaceuticals, Inc. Business Overview
7.17.3 Paratek Pharmaceuticals, Inc. Anthrax Treatment Major Product Offerings
7.17.4 Paratek Pharmaceuticals, Inc. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.17.5 Paratek Pharmaceuticals, Inc. Key News & Latest Developments
7.18 DEINOVE
7.18.1 DEINOVE Company Summary
7.18.2 DEINOVE Business Overview
7.18.3 DEINOVE Anthrax Treatment Major Product Offerings
7.18.4 DEINOVE Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.18.5 DEINOVE Key News & Latest Developments
7.19 BlueWillow Biologics.
7.19.1 BlueWillow Biologics. Company Summary
7.19.2 BlueWillow Biologics. Business Overview
7.19.3 BlueWillow Biologics. Anthrax Treatment Major Product Offerings
7.19.4 BlueWillow Biologics. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.19.5 BlueWillow Biologics. Key News & Latest Developments
7.20 GC Biopharma, corp.
7.20.1 GC Biopharma, corp. Company Summary
7.20.2 GC Biopharma, corp. Business Overview
7.20.3 GC Biopharma, corp. Anthrax Treatment Major Product Offerings
7.20.4 GC Biopharma, corp. Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.20.5 GC Biopharma, corp. Key News & Latest Developments
7.21 Altimmune
7.21.1 Altimmune Company Summary
7.21.2 Altimmune Business Overview
7.21.3 Altimmune Anthrax Treatment Major Product Offerings
7.21.4 Altimmune Anthrax Treatment Sales and Revenue in Global (2019-2024)
7.21.5 Altimmune Key News & Latest Developments
8 Global Anthrax Treatment Production Capacity, Analysis
8.1 Global Anthrax Treatment Production Capacity, 2019-2030
8.2 Anthrax Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Anthrax Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anthrax Treatment Supply Chain Analysis
10.1 Anthrax Treatment Industry Value Chain
10.2 Anthrax Treatment Upstream Market
10.3 Anthrax Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anthrax Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anthrax Treatment in Global Market
Table 2. Top Anthrax Treatment Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Anthrax Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Anthrax Treatment Revenue Share by Companies, 2019-2024
Table 5. Global Anthrax Treatment Sales by Companies, (K Units), 2019-2024
Table 6. Global Anthrax Treatment Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Anthrax Treatment Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Anthrax Treatment Product Type
Table 9. List of Global Tier 1 Anthrax Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anthrax Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anthrax Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Anthrax Treatment Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Anthrax Treatment Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Anthrax Treatment Sales (K Units), 2019-2024
Table 15. By Type - Global Anthrax Treatment Sales (K Units), 2025-2030
Table 16. By Application ? Global Anthrax Treatment Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Anthrax Treatment Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Anthrax Treatment Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Anthrax Treatment Sales (K Units), 2019-2024
Table 20. By Application - Global Anthrax Treatment Sales (K Units), 2025-2030
Table 21. By Region ? Global Anthrax Treatment Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Anthrax Treatment Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Anthrax Treatment Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Anthrax Treatment Sales (K Units), 2019-2024
Table 25. By Region - Global Anthrax Treatment Sales (K Units), 2025-2030
Table 26. By Country - North America Anthrax Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Anthrax Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Anthrax Treatment Sales, (K Units), 2019-2024
Table 29. By Country - North America Anthrax Treatment Sales, (K Units), 2025-2030
Table 30. By Country - Europe Anthrax Treatment Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Anthrax Treatment Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Anthrax Treatment Sales, (K Units), 2019-2024
Table 33. By Country - Europe Anthrax Treatment Sales, (K Units), 2025-2030
Table 34. By Region - Asia Anthrax Treatment Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Anthrax Treatment Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Anthrax Treatment Sales, (K Units), 2019-2024
Table 37. By Region - Asia Anthrax Treatment Sales, (K Units), 2025-2030
Table 38. By Country - South America Anthrax Treatment Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Anthrax Treatment Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Anthrax Treatment Sales, (K Units), 2019-2024
Table 41. By Country - South America Anthrax Treatment Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Anthrax Treatment Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Anthrax Treatment Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Anthrax Treatment Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Anthrax Treatment Sales, (K Units), 2025-2030
Table 46. Alembic Pharmaceuticals Company Summary
Table 47. Alembic Pharmaceuticals Anthrax Treatment Product Offerings
Table 48. Alembic Pharmaceuticals Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Alembic Pharmaceuticals Key News & Latest Developments
Table 50. Integrated Bio Therapeutics Inc. Company Summary
Table 51. Integrated Bio Therapeutics Inc. Anthrax Treatment Product Offerings
Table 52. Integrated Bio Therapeutics Inc. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Integrated Bio Therapeutics Inc. Key News & Latest Developments
Table 54. Sun Pharmaceutical Industries Ltd. Company Summary
Table 55. Sun Pharmaceutical Industries Ltd. Anthrax Treatment Product Offerings
Table 56. Sun Pharmaceutical Industries Ltd. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 58. Zydus Group Company Summary
Table 59. Zydus Group Anthrax Treatment Product Offerings
Table 60. Zydus Group Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Zydus Group Key News & Latest Developments
Table 62. Bayer AG Company Summary
Table 63. Bayer AG Anthrax Treatment Product Offerings
Table 64. Bayer AG Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Bayer AG Key News & Latest Developments
Table 66. Pfizer Inc. Company Summary
Table 67. Pfizer Inc. Anthrax Treatment Product Offerings
Table 68. Pfizer Inc. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Pfizer Inc. Key News & Latest Developments
Table 70. EMERGENT Company Summary
Table 71. EMERGENT Anthrax Treatment Product Offerings
Table 72. EMERGENT Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. EMERGENT Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Anthrax Treatment Product Offerings
Table 76. Sanofi Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Sanofi Key News & Latest Developments
Table 78. Elusys Therapeutics Company Summary
Table 79. Elusys Therapeutics Anthrax Treatment Product Offerings
Table 80. Elusys Therapeutics Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Elusys Therapeutics Key News & Latest Developments
Table 82. Porton Biopharma Company Summary
Table 83. Porton Biopharma Anthrax Treatment Product Offerings
Table 84. Porton Biopharma Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Porton Biopharma Key News & Latest Developments
Table 86. Lupin Company Summary
Table 87. Lupin Anthrax Treatment Product Offerings
Table 88. Lupin Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Lupin Key News & Latest Developments
Table 90. Soligenix Company Summary
Table 91. Soligenix Anthrax Treatment Product Offerings
Table 92. Soligenix Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Soligenix Key News & Latest Developments
Table 94. Takeda Pharmaceutical Company Limited Company Summary
Table 95. Takeda Pharmaceutical Company Limited Anthrax Treatment Product Offerings
Table 96. Takeda Pharmaceutical Company Limited Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 98. Teva Pharmaceutical Industries Ltd. Company Summary
Table 99. Teva Pharmaceutical Industries Ltd. Anthrax Treatment Product Offerings
Table 100. Teva Pharmaceutical Industries Ltd. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 102. ARISTO Pharmaceuticals Private Limited Company Summary
Table 103. ARISTO Pharmaceuticals Private Limited Anthrax Treatment Product Offerings
Table 104. ARISTO Pharmaceuticals Private Limited Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. ARISTO Pharmaceuticals Private Limited Key News & Latest Developments
Table 106. INDOCO REMEDIES LTD. Company Summary
Table 107. INDOCO REMEDIES LTD. Anthrax Treatment Product Offerings
Table 108. INDOCO REMEDIES LTD. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. INDOCO REMEDIES LTD. Key News & Latest Developments
Table 110. Paratek Pharmaceuticals, Inc. Company Summary
Table 111. Paratek Pharmaceuticals, Inc. Anthrax Treatment Product Offerings
Table 112. Paratek Pharmaceuticals, Inc. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. Paratek Pharmaceuticals, Inc. Key News & Latest Developments
Table 114. DEINOVE Company Summary
Table 115. DEINOVE Anthrax Treatment Product Offerings
Table 116. DEINOVE Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 117. DEINOVE Key News & Latest Developments
Table 118. BlueWillow Biologics. Company Summary
Table 119. BlueWillow Biologics. Anthrax Treatment Product Offerings
Table 120. BlueWillow Biologics. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 121. BlueWillow Biologics. Key News & Latest Developments
Table 122. GC Biopharma, corp. Company Summary
Table 123. GC Biopharma, corp. Anthrax Treatment Product Offerings
Table 124. GC Biopharma, corp. Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 125. GC Biopharma, corp. Key News & Latest Developments
Table 126. Altimmune Company Summary
Table 127. Altimmune Anthrax Treatment Product Offerings
Table 128. Altimmune Anthrax Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 129. Altimmune Key News & Latest Developments
Table 130. Anthrax Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 131. Global Anthrax Treatment Capacity Market Share of Key Manufacturers, 2021-2024
Table 132. Global Anthrax Treatment Production by Region, 2019-2024 (K Units)
Table 133. Global Anthrax Treatment Production by Region, 2025-2030 (K Units)
Table 134. Anthrax Treatment Market Opportunities & Trends in Global Market
Table 135. Anthrax Treatment Market Drivers in Global Market
Table 136. Anthrax Treatment Market Restraints in Global Market
Table 137. Anthrax Treatment Raw Materials
Table 138. Anthrax Treatment Raw Materials Suppliers in Global Market
Table 139. Typical Anthrax Treatment Downstream
Table 140. Anthrax Treatment Downstream Clients in Global Market
Table 141. Anthrax Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anthrax Treatment Segment by Type in 2023
Figure 2. Anthrax Treatment Segment by Application in 2023
Figure 3. Global Anthrax Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anthrax Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anthrax Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. Anthrax Treatment Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anthrax Treatment Revenue in 2023
Figure 9. By Type - Global Anthrax Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Anthrax Treatment Revenue Market Share, 2019-2030
Figure 11. By Type - Global Anthrax Treatment Sales Market Share, 2019-2030
Figure 12. By Type - Global Anthrax Treatment Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Anthrax Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Anthrax Treatment Revenue Market Share, 2019-2030
Figure 15. By Application - Global Anthrax Treatment Sales Market Share, 2019-2030
Figure 16. By Application - Global Anthrax Treatment Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Anthrax Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Anthrax Treatment Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Anthrax Treatment Revenue Market Share, 2019-2030
Figure 20. By Region - Global Anthrax Treatment Sales Market Share, 2019-2030
Figure 21. By Country - North America Anthrax Treatment Revenue Market Share, 2019-2030
Figure 22. By Country - North America Anthrax Treatment Sales Market Share, 2019-2030
Figure 23. US Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Anthrax Treatment Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Anthrax Treatment Sales Market Share, 2019-2030
Figure 28. Germany Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. France Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Anthrax Treatment Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Anthrax Treatment Sales Market Share, 2019-2030
Figure 37. China Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. India Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Anthrax Treatment Revenue Market Share, 2019-2030
Figure 43. By Country - South America Anthrax Treatment Sales Market Share, 2019-2030
Figure 44. Brazil Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Anthrax Treatment Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Anthrax Treatment Sales Market Share, 2019-2030
Figure 48. Turkey Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Anthrax Treatment Revenue, (US$, Mn), 2019-2030
Figure 52. Global Anthrax Treatment Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Anthrax Treatment by Region, 2023 VS 2030
Figure 54. Anthrax Treatment Industry Value Chain
Figure 55. Marketing Channels
